Citing opioid crisis, feds seek rule change for drugmakers

Drugmakers would be required to identify the legitimate need for controlled substances to justify their production under a proposed rule intended to rein in the diversion of drugs for illicit purposes.

The Drug Enforcement Administration announced the proposed rule change Tuesday.

According to the DEA, current regulations were issued in 1971 but need to be updated to reflect the nation's opioid abuse crisis and changes in the manufacture of controlled substances.

West Virginia Attorney General Patrick Morrisey sought to limit how many opioid pills can be manufactured each year. Morrisey has said evidence of diversion had been ignored for years.

The proposed rule seeks input from states and .


Explore further

Ohio sues five drugmakers over role in opioid crisis

© 2018 The Associated Press. All rights reserved.

Citation: Citing opioid crisis, feds seek rule change for drugmakers (2018, April 18) retrieved 26 March 2019 from https://medicalxpress.com/news/2018-04-citing-opioid-crisis-feds-drugmakers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more